| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996386935303316 |
|
|
Autore |
Erasmus Desiderius <d. 1536.> |
|
|
Titolo |
Preparation to deathe [[electronic resource] ] : A booke as deuout as eloquent, compiled by Erasmus Roterodame |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
[Londini, : In aedibus Thomae Bertheleti regii impressoris. excus., Annno. M. D. XXXVIII. [1538]] |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
A translation of: Erasmus, Desiderius. De praeparatione ad mortem. |
Imprint from colophon. |
Signatures: A-F Gâ´. |
Reproduction of the original in the Folger Shakespeare Library. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910829111903321 |
|
|
Autore |
Askari Arman T |
|
|
Titolo |
Management strategies in antithrombotic therapy / / by Arman Askari and Adrian W. Messerli |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester ; ; Hoboken, N.J., : John Wiley and Sons, c2007 |
|
|
|
|
|
|
|
ISBN |
|
9786612348259 |
9781282348257 |
1282348256 |
9780470518137 |
0470518138 |
9780470518144 |
0470518146 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (372 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Thrombolytic therapy |
Thrombosis - Treatment |
Fibrinolytic agents |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Thrombosis and antithrombotics in vascular disease -- Aspirin -- Thienopyridines, ticlopidine, and clopidogrel -- Platelet glycoprotein IIb/IIIa inhibitors -- Unfractionated heparin -- Low-molecular-weight heparins -- Direct thrombin inhibitors -- Fibrinolytic agents -- Acute ST-segment elevation myocardial infarction -- Acute coronary syndromes / non-ST-segment elevation myocardial infarction -- Anticoagulation strategies for patients undergoing percutaneous coronary intervention -- Venous thromboembolic disease -- Heparin-induced thrombocytopenia. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute coronary syndromes, including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction. More and more individuals are |
|
|
|
|
|
|
|
|
|
|
stricken with an acute MI and undergo a percutaneous coronary intervention (PCI). Several reasons apply, including an increasingly aged population, the growing burden of chronic risk factors such as diabetes, obesity, sedentary behaviour, and improvements in e |
|
|
|
|
|
| |